SecBot SecBot
PRESS-RELEASE ·Filed Apr 17, 2026

CELU

Celularity Inc.
BEARISH
Impact 6/10
Horizonweeks Processed6mo ago WireGlobeNewswire
Press release · Activist
Actionable Insight ▼ Bearish

Monitor for the submission of the compliance plan to Nasdaq and the eventual filing of the 10-K. Failure to file within the next few weeks increases delisting risk, which could trigger forced selling by index or fund holders.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
CELU ▼ -37.10% at T+60d
SHORT call ✓ call won +37.10% · α vs SPY +43.87% · entry $1.24 → $0.7800
Entry = T+0 close
Apr 17, 2026
via day close
T+1d
-1.61%
call +1.61% · α +0.96%
$1.22
settled 6mo ago
T+5d
-20.16%
call +20.16% · α +21.07%
$0.9900
settled 6mo ago
T+20d
-35.65%
call +35.65% · α +39.85%
$0.7980
settled 6mo ago
T+60d
-37.10%
call +37.10% · α +43.87%
$0.7800
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Celularity Inc. received a Nasdaq delisting notice due to its failure to file its 2025 Form 10-K on time. The company has 60 days to submit a compliance plan and expects to file the report in the coming weeks, but there is no guarantee it will regain compliance within the allowed timeframe.

Key Facts

  • Celularity received a Nasdaq delisting notice for failing to file its 2025 Form 10-K.
  • The company has 60 days to submit a compliance plan; Nasdaq may grant up to 180 additional days to file.
  • Stock and warrants continue to trade under CELU and CELUW.
  • Company expects to file the 10-K in the coming weeks, but provides no assurance.

Financial Impact

Regulatory and operational risk due to late filing; potential delisting if compliance not achieved.

compliance statusinvestor confidencetrading status

Risk Factors

  • Nasdaq may reject the compliance plan or deny an extension.
  • Failure to file the 10-K in time could lead to delisting, reducing liquidity and investor access.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3276501
15 reports for CELU
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CELU — sortable, filterable
TypeNow
Oct 20, 2026
6d ago
10-K/A
BEARISH ★ 5/10
$1.26awaiting T+60—$0.7500 (+40.48%)
Sep 30, 2026
26d ago
Press Release
NEUTRAL ★ 4/10
$1.35awaiting T+60—$0.7500 (−44.44%)
Sep 29, 2026
27d ago
8-K
NEUTRAL ★ 4/10
$1.35awaiting T+60—$0.7500 (−44.44%)
Sep 28, 2026
28d ago
SC 13D/A
BEARISH ★ 7/10
$1.40awaiting T+60—$0.7500 (+46.43%)
Sep 28, 2026
28d ago
8-K
BEARISH ★ 7/10
$1.40awaiting T+60—$0.7500 (+46.43%)
Sep 24, 2026
4w ago
Press Release
MIXED ★ 6/10
$1.32awaiting T+60—$0.7500 (−43.18%)
Sep 14, 2026
6w ago
8-K
MIXED ★ 5/10
$1.40awaiting T+60—$0.7500 (−46.43%)
Aug 25, 2026
8w ago
Press Release
BEARISH ★ 7/10
$0.8804awaiting T+60—$0.7500 (+14.81%)
Aug 7, 2026
11w ago
8-K
BEARISH ★ 5/10
$0.6866awaiting T+60—$0.7500 (−9.23%)
Jun 30, 2026
16w ago
8-K
BEARISH ★ 6/10
$0.5979 $1.15▼ −92.34%▼ −88.78%$0.7500 (−25.44%)
Showing 10 of 15

US Market Status

Market Closed — Opens in 4h 2m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 17, 2026